Susan E. Bray

2.3k citations

40 papers · 1.7k indexed · h-index 20

Cancer Research top 5%
Oncology top 5%
- Cancer-related Molecular Pathways 17
Molecular Biology top 10%
- Metabolism, Diabetes, and Cancer 5
- RNA modifications and cancer 3
- PI3K/AKT/mTOR signaling in cancer 2
- Retinoids in leukemia and cellular processes 2
Cell Biology top 10%
- Microtubule and mitosis dynamics 2
Dermatology top 5%
Genetics
- Estrogen and related hormone effects 5
Pharmacology
- Pharmacogenetics and Drug Metabolism 2

Co-authors: Colin A. Purdie Lee B. Jordan Alastair M. Thompson Sirwan Hadad Philip Quinlan Gillian Smith Probir Chakravarty Michelle Ferguson
Cited by: Cancer Research Oncology Molecular Biology
Journals: British Journal of Cancer (4 papers)Breast Cancer Research (3 papers)Journal of Clinical Oncology (3 papers)
Partner nations: United Kingdom United States France

In The Last Decade

Susan E. Bray

38 papers receiving 1.7k citations

Peers

Countries citing papers authored by Susan E. Bray

Since Specialization

Citations

This map shows the geographic impact of Susan E. Bray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Bray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Bray more than expected).

Fields of papers citing papers by Susan E. Bray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Bray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Bray. The network helps show where Susan E. Bray may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Susan E. Bray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Susan E. Bray Line = papers co-authored together Susan E. Bray links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinoma British Journal of Cancer ·Lindsay C. Spender,Alip Binaryan Sudiro,Mark Baxter,Júlio Marcente Carlos,K. E. Walker,L. B. Lopes,Zohreh Khammari,Yury Kapelyukh,Susan E. Bray,B. Lvov,Peter G Beidler,Gareth J. Inman,Shaun Walsh,Karen Blyth,Russell Petty	2025	0
2	Female Sex but Not Oestrogen Receptor Expression Predicts Survival in Advanced Gastroesophageal Adenocarcinoma—A Post-hoc Analysis of the GO2 Trial Cancers ·Mark Baxter,Lindsay C. Spender,Shaun Walsh,Susan E. Bray,Gholamali Ali Nematollahi,B. Lvov,Peter Hall,Michel Seymour,Russell Petty,(unknown)	2023	2
3	The amino-acid stress sensing eIF2α kinase GCN2 is a survival biomarker for malignant mesothelioma PubMed ·Deborah Ferrara,Susan E. Bray,Neil M. Kernohan,سەركەوت عمر ابراهیم,Hadar Brayer,Glenn R. Masson	2023	1
4	Cluster analyses of the TCGA and a TMA dataset using the coexpression of HSP27 and CRYAB improves alignment with clinical-pathological parameters of breast cancer and suggests different epichaperome influences for each sHSP Cell Stress and Chaperones ·Philip Quinlan,Hélène Masson,Nigel P. Mongan,Lee B. Jordan,Susan E. Bray,A. G. Krylovetskii,A Ashfield,近畿大学大学院農学研究科,Paul van den IJssel,Alastair M. Thompson,Roy A. Quinlan	2022	3
5	Multimodality Characterization of Cancer-Associated Fibroblasts in Tumor Microenvironment and Its Correlation With Ultrasound Shear Wave-Measured Tissue Stiffness in Localized Prostate Cancer Frontiers in Oncology ·Marcos André de Souza Lima,Xinyu Zhang,宮本武之助,Susan E. Bray,Neil M. Kernohan,Jennifer A. Wilson,Chunhui Li,Ghulam Nabi	2022	5
6	IL-15 and PIM kinases direct the metabolic programming of intestinal intraepithelial lymphocytes Nature Communications ·Joseph Cao,Jaspyr Sanford,Julia M. Marchingo,François Singh,Susan E. Bray,Nolfi S. Tueno,Yen Bao Luong-Thanh,Mahima Swamy	2021	15
7	EMSY expression affects multiple components of the skin barrier with relevance to atopic dermatitis Journal of Allergy and Clinical Immunology ·Martina S. Elias,A. N. Nechay,Judit Reményi,James Abbott,Susan E. Bray,Christian Cole,Sharon Edwards,Marek Gierliński,姚玉秀,John A. McGrath,William V. Nicholson,Lavinia Paternoster,Alan R. Prescott,Sara ten Have,Phillip D. Whitfield,Angus I. Lamond,Sara Brown	2019	19
8	MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4 PLoS ONE ·Lynnette Marcar,槙山和秀,John M Hourihan,Susan E. Bray,Philip Quinlan,Lee B. Jordan,Alastair M. Thompson,Ted R. Hupp,David W. Meek	2015	38
9	Phenformin as prophylaxis and therapy in breast cancer xenografts British Journal of Cancer ·M. Virginia C. L. Appleyard,Karen Murray,Philip J. Coates,Stephan Wullschleger,Susan E. Bray,Neil M. Kernohan,S. Fleming,Dario R. Alessi,Anne M. Thompson	2012	89
10	Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53mutation and poor clinical outcome Breast Cancer Research ·B. Lvov,Colin A. Purdie,Susan E. Bray,Philip Quinlan,Lee B. Jordan,Alastair M. Thompson,David W. Meek	2012	82
11	Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial Breast Cancer Research and Treatment ·Sirwan Hadad,Takayuki Iwamoto,Lee B. Jordan,Colin A. Purdie,Susan E. Bray,Lee D. Baker,Gera L. Jellema,Steve Deharo,D. Grahame Hardie,Lajos Pusztai,Stacy Moulder-Thompson,John Dewar,Alastair M. Thompson	2011	231
12	The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53, and is inversely associated with Δ133p53 expression in breast cancer Oncogene ·Hannah C. Moore,Lee B. Jordan,Susan E. Bray,Lee D. Baker,Philip Quinlan,Colin A. Purdie,Alastair M. Thompson,Jean‐Christophe Bourdon,Frances V. Fuller-Pace	2010	28
13	CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy Breast Cancer Research ·Alfonso Higueras Lara,Susan E. Bray,Margaret Johnson,Philip Quinlan,中部日本新聞社,D. Gareth Evans,Robert B. Clarke,HJ Lawrence,Anthony Howell,Ayşe Latif,Fiona King,Grantland Hillman,Marcel Fontecha,William G. Newman	2010	6
14	Wnt5a Exhibits Layer-Specific Expression in Adult Skin, Is Upregulated in Psoriasis, and Synergizes with Type 1 Interferon PLoS ONE ·Małgorzata Romanowska,Alan Evans,Sonali Vijay Deshmukh,Susan E. Bray,Kathleen McLean,陈泽环,John Foerster	2009	55
15	Histological evaluation of AMPK signalling in primary breast cancer BMC Cancer ·Sirwan Hadad,Lee D. Baker,Philip Quinlan,Katherine Robertson,Susan E. Bray,George Thomson,Alexei Barchukov,Lee B. Jordan,Colin A. Purdie,D. Grahame Hardie,Stewart Fleming,Alastair M. Thompson	2009	148
16	Gene expression in colorectal neoplasia: modifications induced by tissue ischaemic time and tissue handling protocol Histopathology ·Susan E. Bray,F. Paulin,G.P. Rajendran,pJianMing Huangp,圭二松田,David A. Levison,R. Steele,Neil M. Kernohan	2009	41
17	Seliciclib (CYC202, R‐roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model International Journal of Cancer ·R . I Zolotareva,Mary O’Neill,Karen Murray,F. Paulin,Susan E. Bray,Neil M. Kernohan,David A. Levison,David P. Lane,Alastair M. Thompson	2008	43
18	Lesions resembling Langerhans cell histiocytosis in association with other lymphoproliferative disorders: a reactive or neoplastic phenomenon? Human Pathology ·Lesley Christie,Alan Evans,Susan E. Bray,Mark E. Smith,Neil M. Kernohan,David A. Levison,John R. Goodlad	2005	50
19	Activity of MDI-301, a novel synthetic retinoid, in xenografts Anti-Cancer Drugs ·Virginia Appleyard,Jordi Garrigó Rusiñol,Karen Murray,Susan E. Bray,George Thomson,Neil M. Kernohan,James Varani,Jian Zhang,Alastair M. Thompson	2004	7
20	Transcriptional activation of tyrosinase and TRP-1 by p53 links UV irradiation to the protective tanning response The Journal of Pathology ·Karin Nylander,Jean‐Christophe Bourdon,Susan E. Bray,Neil K. Gibbs,Richard Kay,Ian R. Hart,Peter A. Hall	2000	83

About Susan E. Bray

Susan E. Bray is a scholar working on Oncology, Aging, Cancer Research, Immunology and Allergy and Molecular Biology, having authored 40 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (17 papers), Metabolism, Diabetes, and Cancer (5 papers), Estrogen and related hormone effects (5 papers), RNA modifications and cancer (3 papers), Microtubule and mitosis dynamics (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Cancer Research (405 citations), Oncology (711 citations), Molecular Biology (1.1k citations), Cell Biology (150 citations) and Dermatology (76 citations). Susan E. Bray has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Colin A. Purdie, Lee B. Jordan, Alastair M. Thompson, Sirwan Hadad, Philip Quinlan, Gillian Smith, Probir Chakravarty, Michelle Ferguson, Aparajitha Vaidyanathan and Anne‐Louise Gannon. Their work appears in journals such as British Journal of Cancer, Breast Cancer Research, Journal of Clinical Oncology, Oncogene and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact